Custom Labels Requirement
ID: PR91914Type: Sources Sought
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFCENTERS FOR DISEASE CONTROL AND PREVENTIONCDC OFFICE OF ACQUISITION SERVICESATLANTA, GA, 30333, USA

NAICS

Medical Laboratories (621511)

PSC

MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES (6515)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)

Original Source

https://sam.gov/opp/8fd961041ec04a1198fc06938e85823f/view
Timeline
  1. 1
    Posted Mar 25, 2025, 12:00 AM UTC
  2. 2
    Updated Mar 25, 2025, 12:00 AM UTC
  3. 3
    Due Apr 10, 2025, 2:00 PM UTC
Description

The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking to procure custom labeling materials through a sole-source contract with Multisystems Inc. This procurement involves specialized RM 66171 Clear PolyPro labels and Thermal Transfer Ribbon Wax/Resin, which are essential for labeling specimen tubes that must endure extremely low temperatures. The labels are critical for the CDC's dengue research specimen handling and must meet specific requirements, including compatibility with the ZT 230 Printer and compliance with CLIA regulations. Interested parties are encouraged to express their capability to fulfill these requirements by April 4, 2025, and should contact Ashley Williams at dal3@cdc.gov or Sheena Delaine at kpz5@cdc.gov for further information.

Point(s) of Contact
Ashley Williams
dal3@cdc.gov
Sheena Delaine
kpz5@cdc.gov
Files
Title
Posted
A13- SSJ_Redacted.pdf
Mar 25, 2025, 5:05 PM UTC
The document outlines the justification process for a sole source procurement under $250,000 by the Centers for Disease Control and Prevention (CDC) for customized labels used in dengue research specimen handling. The sole source acquisition requires detailed justification, following FAR regulations, and is initiated by the CDC's Dengue Branch. The proposed vendor, Multisystems, Inc., is uniquely capable of supplying thermal printing and cryo-stable labels specifically designed for the CDC's needs, including compliance with CLIA regulations. The urgency of the requirement stems from the specialized nature of the labels, which must withstand extreme temperatures during specimen storage. Alternatives were considered, but they did not meet the specific size and functional requirements essential for the laboratory’s operations. The justification highlights that Multisystems provides unique, tailored solutions that align with the CDC's workflow, thus supporting the necessity for sole source procurement. This document serves to ensure compliance with government procurement policies, reinforcing the need for specialized supplies in critical research environments while underlining the importance of efficiency and continuity in public health initiatives.
A22-NOI.pdf
Mar 25, 2025, 5:05 PM UTC
The Centers for Disease Control and Prevention (CDC), through its National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), intends to issue a sole-source contract with MULTISYSTEMS INC. for the acquisition of specialized labeling materials and thermal transfer ribbons. This procurement includes RM 66171 Clear PolyPro labels (3.75” x 4.375”) and Thermal Transfer Ribbon Wax/Resin, both of which are crucial for labeling specimen tubes at extremely low temperatures. The labels must be pre-printed in white, require two passes of UV treatment, and be compatible with the ZT 230 Printer used in their laboratories. Delivery is planned in three batches, with specific quantities required by April, June, and August of 2025. The announcement specifies that the government seeks to negotiate with only one source under FAR regulations, but encourages other interested parties to express their capability to fulfill the requirements by April 4, 2025. This notice highlights the CDC's operational needs for cryo-stable labeling solutions critical for their laboratory processes.
Lifecycle
Title
Type
Custom Labels Requirement
Currently viewing
Sources Sought
Similar Opportunities
CDC DFWED NARST Sensititre Supplies
Buyer not available
The Centers for Disease Control and Prevention (CDC) is seeking to award a sole source contract for antimicrobial resistance testing supplies, specifically Sensititre™ broth microdilution testing products, from ThermoFisher Scientific. This procurement is essential for the National Antimicrobial Resistance Monitoring System (NARMS), which has utilized these proprietary materials since 1996 to ensure a standardized approach to monitoring enteric bacteria resistance. The unique nature of these supplies necessitates this sole source approach, as alternatives would require significant investments in new equipment and validation processes, potentially disrupting critical surveillance efforts. Interested parties may respond within 15 days to express their interest, with proposals directed to contract specialist Ashley Williams at dal3@cdc.gov.
Serological Assays for the Detection and Characterization of Influenza Viruses
Buyer not available
The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is soliciting proposals for a contract to provide serological assays for the detection and characterization of influenza viruses. The primary objective of this procurement is to support the CDC's Influenza Division by conducting hemagglutination inhibition assays on approximately 6,000 human serum samples annually and developing new serology platforms to enhance testing capabilities. This contract is critical for improving influenza surveillance and vaccine effectiveness studies, ensuring timely and accurate public health responses. Interested vendors should note that the new ship date for assays is March 31, 2025, with results due by April 15, 2025, and can contact Jennifer Gartzke at jgartzke@cdc.gov or 404-498-0020 for further information.
Notice of Intent to Sole Source - University of Michigan - Vaccine Cost-Effectiveness Models
Buyer not available
The Centers for Disease Control and Prevention (CDC) intends to award a sole source firm fixed price contract to the University of Michigan for access to proprietary models that assess the cost-effectiveness of vaccines. This procurement aims to secure detailed reports based on these models, which are deemed essential for the CDC's vaccine evaluation efforts, as no other models are known to provide the required level of detail. The contract will cover a base year with four additional option years, and interested parties may express their interest or capability to respond within fifteen days of this notice. Responses should be directed to contract specialists William O’Bryan at rvq0@cdc.gov and Ruben Reyes-Colon at qmz3@cdc.gov by 3:00 PM EDT on April 11, 2025.
Notice of Intent to Sole Source - Optimoz Inc
Buyer not available
The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), intends to negotiate a sole source contract with Optimoz Inc. for operations and maintenance support services related to the Virgin Islands’ Immunization Information System (IIS). This procurement aims to enhance the functionality and operational efficiency of IISs, which are critical for assessing vaccination rates and managing public health interventions to prevent vaccine-preventable diseases. The contract is justified under FAR 6.302-1, as Optimoz Inc. is the only vendor capable of providing these services without causing disruption or inefficiency in the existing IIS framework. Interested parties may submit capability statements or proposals to Matthew Nelson at mnelson2@cdc.gov by April 11, 2025, at 4:30 PM EST for consideration.
6515--(North)PND 04-04-2025 -442 Steridate Label Systems (VA-25-00058546)
Buyer not available
The Department of Veterans Affairs (VA) is seeking to procure a Sterile Processing Label System from MED VANTAGE INC. to enhance the labeling and tracking capabilities within its Sterile Processing Services and Endoscopy Section at the Cheyenne VA Medical Center. The system is required to feature durable surfaces, customizable label formats, barcode generation, and a database to minimize manual input errors, thereby improving process integrity and patient safety during sterilization and preparation processes. Interested vendors may express their capability to meet these requirements by the response deadline of April 11, 2025, and must be registered in the System for Award Management (SAM). For further inquiries, contact Contract Specialist Peyton Wilkerson at peyton.wilkerson@va.gov or call 303-712-5831.
Solicitation - World Trade Center Health Program - Survivor Clinical Center of Excellence
Buyer not available
The Department of Health and Human Services, through the Centers for Disease Control and Prevention (CDC), is soliciting proposals for the Survivor Clinical Center of Excellence (CCE) under Solicitation 75D301-25-R-00088. The objective is to procure healthcare services for eligible survivors of the September 11, 2001, terrorist attacks, focusing on health monitoring, diagnosis, and treatment for individuals residing in the New York Metropolitan Area. This initiative is critical for providing ongoing medical support to a population significantly impacted by the attacks, ensuring they receive necessary care and resources. Interested contractors must submit their proposals electronically, adhering to the outlined requirements and deadlines, with questions directed to the primary contacts, Serina Allingham at xog9@cdc.gov or Patrick Winders at vxx6@cdc.gov.
Purchase of Lab Supplies
Buyer not available
The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified vendors to provide various lab supplies, including cleaning and sanitation products, under solicitation number 75N98025Q00021. The procurement aims to ensure the NIH is equipped with essential supplies such as paper towels, disinfectant wipes, and hand soap, which are critical for maintaining hygiene and safety in healthcare environments. This opportunity includes a partial small business set-aside, encouraging participation from small businesses, including service-disabled veteran-owned and women-owned enterprises, with a focus on timely delivery within a 10-day timeframe. Interested vendors must submit their quotes via email by 4:30 PM Eastern Daylight Time on April 9, 2025, and can direct inquiries to Carol Hayden at haydenc@od.nih.gov.
6550--Lab Testing Services - (HIV/HCV/HPV/On)
Buyer not available
The Department of Veterans Affairs is seeking to negotiate a sole-source contract with Roche Diagnostics Corporation for lab testing services related to HIV, HCV, and HPV at the Corporal Michael J. Crescenz VA Medical Center. The contractor will be responsible for providing FDA-approved laboratory systems, instruments, maintenance, and consumables necessary for clinical testing, including a fully automated PCR testing platform with advanced features for real-time detection and minimal maintenance. This procurement is crucial for ensuring the delivery of quality healthcare services to veterans through efficient laboratory solutions. Interested parties must express their interest or submit capabilities by February 13, 2025, and can contact Contract Specialist Yazmin Alvarez at yazmin.alvarez@va.gov or 302-944-2511 x5202 for further information.
Purchase a Direct to Substrate Printer with Maintenance or Warranty for 60 months
Buyer not available
The Defense Logistics Agency (DLA) is seeking to procure a Direct to Substrate printer along with maintenance or warranty services for a duration of 60 months. The printer will be utilized for producing color labels on Avery 2900 face film, which is essential for labeling various printed products. This procurement is part of a broader effort to enhance the DLA's document services capabilities, and it is open to full and open competition following recent amendments. Interested vendors must submit their quotes and all required documentation by April 25, 2025, at 10:00 AM EST, and can direct inquiries to David Purvis at david.1.purvis@dla.mil or by phone at 717-770-4906.
NULISAseq CNS Disease Panel 120 Kit or Equivalent
Buyer not available
The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking information from qualified sources regarding the availability of the Alamar NULISAseq CNS Disease Panel 120 Kit or equivalent products. The objective is to procure three kits to aid in the investigation of biomarkers for neurodegenerative diseases, which are critical for early diagnosis and potential preventive measures. This procurement is essential for the NIH's Laboratory of Clinical Investigation, which focuses on isolating and measuring biomarkers from patient plasma to improve disease detection and management. Interested companies must submit their capability statements by April 11, 2025, to Eric McKay at eric.mckay@nih.gov, ensuring they include relevant details such as their business type and manufacturing information.